128 related articles for article (PubMed ID: 37562556)
1. Spatiotemporally controlled Pseudomonas exotoxin transgene system combined with multifunctional nanoparticles for breast cancer antimetastatic therapy.
Cheng Y; Zou J; He M; Hou X; Wang H; Xu J; Yuan Z; Lan M; Yang Y; Chen X; Gao F
J Control Release; 2024 Mar; 367():167-183. PubMed ID: 37562556
[TBL] [Abstract][Full Text] [Related]
2. A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy.
Hou X; Shou C; He M; Xu J; Cheng Y; Yuan Z; Lan M; Zhao Y; Yang Y; Chen X; Gao F
Acta Pharm Sin B; 2020 Sep; 10(9):1741-1753. PubMed ID: 33088693
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporally controllable diphtheria toxin expression using a light-switchable transgene system combining multifunctional nanoparticle delivery system for targeted melanoma therapy.
He M; Wang Y; Chen X; Zhao Y; Lou K; Wang Y; Huang L; Hou X; Xu J; Cai X; Cheng Y; Lan M; Yang Y; Gao F
J Control Release; 2020 Mar; 319():1-14. PubMed ID: 31838205
[TBL] [Abstract][Full Text] [Related]
4. Light-switchable diphtherin transgene system combined with losartan for triple negtative breast cancer therapy based on nano drug delivery system.
Cheng Y; Sun R; He M; Zhang M; Hou X; Sun Y; Wang J; Xu J; He H; Wang H; Lan M; Zhao Y; Yang Y; Chen X; Gao F
Int J Pharm; 2022 Apr; 618():121613. PubMed ID: 35217071
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of paclitaxel and STAT3 siRNA by a multifunctional nanocomplex for targeted treatment of metastatic breast cancer.
Luo K; Gao Y; Yin S; Yao Y; Yu H; Wang G; Li J
Acta Biomater; 2021 Oct; 134():649-663. PubMed ID: 34289420
[TBL] [Abstract][Full Text] [Related]
6. Her2-Targeted Multifunctional Nano-Theranostic Platform Mediates Tumor Microenvironment Remodeling and Immune Activation for Breast Cancer Treatment.
Zheng D; Wan C; Yang H; Xu L; Dong Q; Du C; Du J; Li F
Int J Nanomedicine; 2020; 15():10007-10028. PubMed ID: 33376321
[TBL] [Abstract][Full Text] [Related]
7. Efficient Sequential Co-Delivery Nanosystem for Inhibition of Tumor and Tumor-Associated Fibroblast-Induced Resistance and Metastasis.
Li C; Wang Z; Zhang Y; Zhu Y; Xu M; Lei H; Zhang D
Int J Nanomedicine; 2024; 19():1749-1766. PubMed ID: 38414527
[TBL] [Abstract][Full Text] [Related]
8. Sequential Rocket-Mode Bioactivating Ticagrelor Prodrug Nanoplatform Combining Light-Switchable Diphtherin Transgene System for Breast Cancer Metastasis Inhibition.
Zou J; Sun R; He M; Chen Y; Cheng Y; Xia C; Ma Y; Zheng S; Fu X; Yuan Z; Lan M; Lou K; Chen X; Gao F
ACS Appl Mater Interfaces; 2023 Nov; 15(46):53198-53216. PubMed ID: 37942626
[TBL] [Abstract][Full Text] [Related]
9. pH-responsive Sulfated Hyaluronic Acid Nanoparticles Targeting Tumor Cells and CAFs for the Treatment of Breast Cancer.
Wang D; Wu J; Qi C; Dong J; Ding X; Yu G; Liu S; Zhang B; Gao Z; Wei X; Liu H
Recent Pat Anticancer Drug Discov; 2022; 18(2):200-210. PubMed ID: 35538821
[TBL] [Abstract][Full Text] [Related]
10. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
[TBL] [Abstract][Full Text] [Related]
11. RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer.
Yadav AS; Radharani NNV; Gorain M; Bulbule A; Shetti D; Roy G; Baby T; Kundu GC
Nanoscale; 2020 May; 12(19):10664-10684. PubMed ID: 32374338
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6-dependent pathway.
Pradhan R; Paul S; Das B; Sinha S; Dash SR; Mandal M; Kundu CN
J Nutr Biochem; 2023 Mar; 113():109257. PubMed ID: 36572069
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an Integrin α
Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
[TBL] [Abstract][Full Text] [Related]
14. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
[TBL] [Abstract][Full Text] [Related]
15. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
16. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
[TBL] [Abstract][Full Text] [Related]
17. Fine tuning the LightOn light-switchable transgene expression system.
Ma Z; Du Z; Chen X; Wang X; Yang Y
Biochem Biophys Res Commun; 2013 Oct; 440(3):419-23. PubMed ID: 24095689
[TBL] [Abstract][Full Text] [Related]
18. Normalizing Tumor Blood Vessels to Improve Chemotherapy and Inhibit Breast Cancer Metastasis by Multifunctional Nanoparticles.
Zeng Y; Zhang S; Li S; Song G; Meng T; Yuan H; Hu F
Mol Pharm; 2023 Oct; 20(10):5078-5089. PubMed ID: 37728215
[TBL] [Abstract][Full Text] [Related]
19. Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer.
Zheng S; Wang J; Ding N; Chen W; Chen H; Xue M; Chen F; Ni J; Wang Z; Lin Z; Jiang H; Liu X; Wang L
J Nanobiotechnology; 2021 Nov; 19(1):381. PubMed ID: 34802453
[TBL] [Abstract][Full Text] [Related]
20. Metabolic reprogramming by dual-targeting biomimetic nanoparticles for enhanced tumor chemo-immunotherapy.
Zang S; Huang K; Li J; Ren K; Li T; He X; Tao Y; He J; Dong Z; Li M; He Q
Acta Biomater; 2022 Aug; 148():181-193. PubMed ID: 35649505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
